Nucleotide substitution: C3856T. Amino acid replacement: S1117L.
Nucleotide substitution: C3347T. Amino acid replacement: S1116L. This amino acid residue is in the C-terminal end of the kinase domain.
C21558298T
C3856T
S1117L | Egfr-PA; S1166L | Egfr-PB
S1117L
The number of limb primordial cells is increased in stage 11 embryos, but the final number of leg disc cells is greatly reduced in stage 15 embryos.
Homozygous embryos show a loss of 3 chordotonal organs per abdominal hemisegment (VChA and two in LCh5).
Malpighian tubules in homozygous embryos are four tiny outpushings of the posterior hindgut. Reduction in size of the tubules is due to reduction in cell number, not cell death.
All or nearly all of the ventral epidermal cells are absent in mutant embryos.
Homozygotes have a severe embryonic phenotype; denticles are missing or severely reduced, and there are head and germ band retraction defects. Complements Egfrf8; a milder embryonic phenotype (in both the cuticle and CNS) than either homozygote is seen in combination with this allele. Shows a rough eye phenotype in combination with EgfrE1.
Homozygotes and hemizygotes display a severe 'flb' phenotype. Embryos produced from heteroallelic combination with Egfrt1 have a severe ventralised phenotype, reduction in size of their dorsal appendage. Individuals are fully viable over the pupal lethals Egfrtop-CA and Egfrtop-EC20 and show a reduction in viability over Egfrtop-EB.
severe allele
Selected as: Embryonic lethal.
Mutation of Egfr that affects the gene function required for embryogenesis, a class II lesion. The allelic series for class II lesions: Egfrtop-101 < Egfrtop-JE14 = Egfrf4 < Egfrf6.
Less than 10% of wild type number of ventral epidermal cells expressing P{lacZ}BP28 are evident in mutant embryos. oc expression is greatly reduced along the midline.
Severe Egfr allele.
Severe mutation.
Class IIA allele. Class II alleles fully or partially complement the developmental defects of Egfrt1 and Egfrtop-CA. Substantially complements the postembryonic lethality of Egfrtop-EC20. Several combinations of Egfr alleles involving Egfrtop-101, Egfrf4, Egfrf8 and Egfrf6 demonstrate interallelic complementation.